Lilly’s Zepbound Beats Wegovy in Weight Loss Trial...
Category : Clinical Trial Update 12 May 2025The trial also showed that treatment with Zepbound achieved a superior average waist circumference r...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Amneal, Apiject Expand BFS to Boost U.S. Sterile D...
Category : Licensing/Collaboration Deal 12 May 2025Amneal Pharmaceuticals and Apiject Systems have announced a strategic partnership to boost domestic...
GSK’s GLISTEN Phase III Trial of Linerixibat Meets...
Category : Clinical Trial Update 9 May 2025GSK plc announced positive results from the GLISTEN phase III trial evaluating linerixibat, an inves...
Boehringer Starts Phase II Trial for Oral Drug in...
Category : Clinical Trial Update 9 May 2025Boehringer Ingelheim announces the start of the JADE phase II clinical study (NCT06769048), investig...
Everest Medicines Announces NMPA Full Approval of...
Category : Approval/Launch 8 May 2025Everest Medicines a biopharmaceutical company focused on the discovery, clinical development, manufa...
Latest Newsletter Post
-
Amneal, Apiject Expand BFS to Boost..
12 May 2025
-
Lilly’s Zepbound Beats Wegovy in We..
12 May 2025
-
Boehringer Starts Phase II Trial fo..
9 May 2025
-
GSK’s GLISTEN Phase III Trial of Li..
9 May 2025
-
Data from Its Ongoing Phase 2 ENSUR..
8 May 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com